cedricmsandersm

Contact cedricmsandersm

login or register to send private messages to this user

All about cedricmsandersm

BUY SLEEPING PILLS - FREE RX, USA PHARMACY
 
 
 
 
 
 
 
 
 
 
 
 
Two recent reports say drugmakers cut Rx ad spending in the first arimidex six months of this year. Among factors driving the drop, he says, sleep medications are fewer drug launches, fear of government regulation and cuts by a few brands that had spent big. cefixime Second-quarter spending in magazines fell 29% to $358million, according to TNS, while radio plummeted 62% to $4million. (c) 2008 USA TODAY, a division of Gannett sleep medications Co. Rival ad tracker Nielsen Monitor-Plus calculates the decline at 4.8% to $2.7 billion. The reports follow a well-publicized Harvard Medical School study that found consumer ads had little effect on prescription medication prescription drug sales. By Kristel Petrecca NEW YORK -- This could make media owners sick. Sepracor's Lunesta, an insomnia drug known for its glowing moth icon, spent $75million on ads pharmacist in the first quarter of 2008 vs.

That if the government gets involved, they'll be worse off." Last month, the Food and Drug Administration stepped up its watch by asking consumers to help watch for false or misleading drug rozerem ads. Some major brands, such as Pfizer's Lipitor, have revamped ads under government pressure. Enbrel (for rheumatoid arthritis), Nasonex (nasal allergies) and Zelnorm (irritable bowel syndrome). $175million in that quarter in 2007. TNS Media Intelligence puts the drop at 3.9% to $2.4 billion.

Researchers focused on ads for three drugs. "The sleep meds pharmaceutical companies perceive the threat of government regulation on marketing to be a stronger threat now than it has been in the past," and are trying to self-regulate, Swallen says. Magazines and radio stations have seen the most drug ad decline. Takeda Pharmaceuticals North America's Rozerem sleep aid, which used offbeat ad characters such as Clement Hersch and a beaver, cut spending from $91million in the first half of 2007 to $15million in the first half this year. Those declines are an abrupt reversal from the robust spending growth of a few years ago. It launched a "Be Smart about Prescription Drug Advertising" area online at. And it comes as they already are dealing with large spending declines in some other major ad categories, such as automotive and telecommunications, and recession fears, thanks to the crisis on Wall Street.

A service of YellowBrix, Inc.. Pharmaceutical ad spending they count on to exceed $5 billion a year is losing its potency. Results sho that direct-to-consumer (DTC) ads